InMode Ltd. (NASDAQ:INMD) Surges 10.61% on Acquisition Speculation

InMode Ltd. (NASDAQ:INMD) surged 10.6093% in pre-market trading on January 27, 2026, fueled by speculation surrounding potential acquisition discussions. The Israeli medical aesthetics firm reportedly is in advanced talks with a foreign investment fund for a $1.1 billion takeover, representing a 23.5% premium to its previous closing price and a significant valuation multiple relative to its $963 million market cap.

Analysts noted the transaction would align with industry trends, as several peers like Syneron and Alma Lasers have been acquired by private equity in recent years. While BTIG maintained a Neutral rating, it acknowledged the deal could address years of stock underperformance amid slowing revenue. The proposed acquisition values InMode at 1.5x EV/Sales and 8.5x P/E based on 2026 estimates, contrasting with its current 6.29x P/E, suggesting undervaluation according to market data.

Recent earnings momentum also contributed to investor optimism. InMode's Q3 2025 results beat expectations, with non-GAAP EPS of $0.38 (5.56% above forecasts) and revenue of $93.16 million ($2.64 million above estimates). The strong performance, combined with robust liquidity (cash exceeding debt), reinforced confidence in the company's strategic position ahead of the potential delisting.

InMode's recent earnings beat expectations and strong liquidity position have generated significant interest in the stock, especially given the potential for a transformative acquisition. The company's fundamentals are supported by a growing demand for non-invasive aesthetic procedures, and its product portfolio has demonstrated solid market penetration. However, the current valuation appears to reflect a speculative premium rather than intrinsic value, requiring closer analysis to assess the sustainability of the stock's performance.